• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非晶态固体分散体的最新进展:处方前研究、制剂策略、技术进步与表征

Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization.

作者信息

Tambe Srushti, Jain Divya, Meruva Sai Kishore, Rongala Gopinath, Juluri Abhishek, Nihalani Girish, Mamidi Hemanth Kumar, Nukala Pavan Kumar, Bolla Pradeep Kumar

机构信息

Department of Pharmaceutical Science and Technology, Institute of Chemical Technology, Mumbai 400019, India.

College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA.

出版信息

Pharmaceutics. 2022 Oct 16;14(10):2203. doi: 10.3390/pharmaceutics14102203.

DOI:10.3390/pharmaceutics14102203
PMID:36297638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9609913/
Abstract

Amorphous solid dispersions (ASDs) are among the most popular and widely studied solubility enhancement techniques. Since their inception in the early 1960s, the formulation development of ASDs has undergone tremendous progress. For instance, the method of preparing ASDs evolved from solvent-based approaches to solvent-free methods such as hot melt extrusion and Kinetisol. The formulation approaches have advanced from employing a single polymeric carrier to multiple carriers with plasticizers to improve the stability and performance of ASDs. Major excipient manufacturers recognized the potential of ASDs and began introducing specialty excipients ideal for formulating ASDs. In addition to traditional techniques such as differential scanning calorimeter (DSC) and X-ray crystallography, recent innovations such as nano-tomography, transmission electron microscopy (TEM), atomic force microscopy (AFM), and X-ray microscopy support a better understanding of the microstructure of ASDs. The purpose of this review is to highlight the recent advancements in the field of ASDs with respect to formulation approaches, methods of preparation, and advanced characterization techniques.

摘要

无定形固体分散体(ASDs)是最受欢迎且研究最广泛的溶解度增强技术之一。自20世纪60年代初问世以来,ASDs的制剂开发取得了巨大进展。例如,制备ASDs的方法从基于溶剂的方法发展到无溶剂方法,如热熔挤出和Kinetisol。制剂方法也从使用单一聚合物载体发展到使用多种带有增塑剂的载体,以提高ASDs的稳定性和性能。主要辅料制造商认识到ASDs的潜力,并开始推出适合配制ASDs的特种辅料。除了差示扫描量热法(DSC)和X射线晶体学等传统技术外,诸如纳米断层扫描、透射电子显微镜(TEM)、原子力显微镜(AFM)和X射线显微镜等最新创新技术有助于更好地理解ASDs的微观结构。本综述的目的是突出ASDs领域在制剂方法、制备方法和先进表征技术方面的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/e49b66e18037/pharmaceutics-14-02203-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/8be36e3fb324/pharmaceutics-14-02203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/3f648cbb7f44/pharmaceutics-14-02203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/6b283e904a45/pharmaceutics-14-02203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/4a7924936076/pharmaceutics-14-02203-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/9dac6d23fd90/pharmaceutics-14-02203-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/5cdab07ee5ee/pharmaceutics-14-02203-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/e49b66e18037/pharmaceutics-14-02203-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/8be36e3fb324/pharmaceutics-14-02203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/3f648cbb7f44/pharmaceutics-14-02203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/6b283e904a45/pharmaceutics-14-02203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/4a7924936076/pharmaceutics-14-02203-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/9dac6d23fd90/pharmaceutics-14-02203-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/5cdab07ee5ee/pharmaceutics-14-02203-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a158/9609913/e49b66e18037/pharmaceutics-14-02203-g007a.jpg

相似文献

1
Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization.非晶态固体分散体的最新进展:处方前研究、制剂策略、技术进步与表征
Pharmaceutics. 2022 Oct 16;14(10):2203. doi: 10.3390/pharmaceutics14102203.
2
Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.热加工创新:热熔挤出和 KinetiSol® 分散技术。
AAPS PharmSciTech. 2020 Nov 8;21(8):312. doi: 10.1208/s12249-020-01854-2.
3
Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.在制备难溶性活性药物成分的固体分散体中使用表面活性剂作为增塑剂:所选固体分散体的稳定性测试
Pharm Res. 2006 Aug;23(8):1928-36. doi: 10.1007/s11095-006-9034-1.
4
Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.热熔挤出和 Kinetisol 分散法制备含热敏性活性成分的固体分散体的融合生产。
Eur J Pharm Biopharm. 2010 Feb;74(2):340-51. doi: 10.1016/j.ejpb.2009.09.007. Epub 2009 Oct 7.
5
Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.利用 Flory-Huggins 相图作为制备无定形固体分散体的预配方工具:热熔挤出法和喷雾干燥法的比较。
J Pharm Pharmacol. 2014 Feb;66(2):256-74. doi: 10.1111/jphp.12141. Epub 2013 Nov 5.
6
Corroborating various material-sparing techniques with hot melt extrusion for the preparation of triclabendazole amorphous solid dispersions.用热熔挤出法与各种节省材料的技术相结合制备三氯苯达唑无定形固体分散体。
Int J Pharm. 2023 Jun 10;640:122989. doi: 10.1016/j.ijpharm.2023.122989. Epub 2023 Apr 28.
7
Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.KinetiSol 分散剂在无增塑剂无定形固体分散体生产中的应用。
Eur J Pharm Sci. 2010 Jun 14;40(3):179-87. doi: 10.1016/j.ejps.2010.03.002. Epub 2010 Mar 15.
8
Orodispersible Polymer Films with the Poorly Water-Soluble Drug, Olanzapine: Hot-Melt Pneumatic Extrusion for Single-Process 3D Printing.含难溶性药物奥氮平的口腔崩解聚合物薄膜:用于单步3D打印的热熔气动挤出法
Pharmaceutics. 2020 Jul 22;12(8):692. doi: 10.3390/pharmaceutics12080692.
9
Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions.反应性熔融挤出法改善萘普生无定形固体分散体的溶出性能和物理稳定性
Mol Pharm. 2017 Mar 6;14(3):658-673. doi: 10.1021/acs.molpharmaceut.6b00960. Epub 2017 Feb 10.
10
Homogeneity of amorphous solid dispersions - an example with KinetiSol.无定形固体分散体的均一性——以 KinetiSol 为例。
Drug Dev Ind Pharm. 2019 May;45(5):724-735. doi: 10.1080/03639045.2019.1569037. Epub 2019 Jan 25.

引用本文的文献

1
Biocompatible Natural Polymer-Based Amorphous Solid Dispersion System Improving Drug Physicochemical Properties, Stability, and Efficacy.基于生物相容性天然聚合物的无定形固体分散体系统改善药物的物理化学性质、稳定性和疗效。
Polymers (Basel). 2025 Jul 28;17(15):2059. doi: 10.3390/polym17152059.
2
Recent Advances in Vitamin E TPGS-Based Organic Nanocarriers for Enhancing the Oral Bioavailability of Active Compounds: A Systematic Review.基于维生素E TPGS的有机纳米载体提高活性化合物口服生物利用度的研究进展:一项系统综述
Pharmaceutics. 2025 Apr 7;17(4):485. doi: 10.3390/pharmaceutics17040485.
3
Oral dosage forms for drug delivery to the colon: an existing gap between research and commercial applications.

本文引用的文献

1
Amorphous Solid Dispersions: Role of the Polymer and Its Importance in Physical Stability and In Vitro Performance.无定形固体分散体:聚合物的作用及其在物理稳定性和体外性能方面的重要性。
Pharmaceutics. 2022 Aug 22;14(8):1747. doi: 10.3390/pharmaceutics14081747.
2
Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic.羟丙甲纤维素醋酸琥珀酸酯作为一种非凡的聚合物在无定形固体分散体配方中的应用:从实验室到临床的综述。
Eur J Pharm Biopharm. 2022 Aug;177:289-307. doi: 10.1016/j.ejpb.2022.07.010. Epub 2022 Jul 21.
3
Detecting Crystallinity Using Terahertz Spectroscopy in 3D Printed Amorphous Solid Dispersions.
用于结肠给药的口服剂型:研究与商业应用之间的现有差距。
J Mater Sci Mater Med. 2025 Mar 5;36(1):24. doi: 10.1007/s10856-025-06868-5.
4
Enhancing Process Control and Quality in Amorphous Solid Dispersions Using In-Line UV-Vis Monitoring of L* as a Real-Time Response.利用L*的在线紫外-可见监测作为实时响应来增强无定形固体分散体的过程控制和质量
Pharmaceutics. 2025 Jan 23;17(2):151. doi: 10.3390/pharmaceutics17020151.
5
Enhancing Patient-Centric Drug Development: Coupling Hot Melt Extrusion with Fused Deposition Modeling and Pressure-Assisted Microsyringe Additive Manufacturing Platforms with Quality by Design.加强以患者为中心的药物研发:将热熔挤出与熔融沉积建模以及压力辅助微注射器增材制造平台相结合,并采用质量源于设计理念。
Pharmaceutics. 2024 Dec 25;17(1):14. doi: 10.3390/pharmaceutics17010014.
6
Mechanistic Insights into Amorphous Solid Dispersions: Bridging Theory and Practice in Drug Delivery.非晶态固体分散体的作用机制见解:药物递送中理论与实践的桥梁
Pharm Res. 2025 Jan;42(1):1-23. doi: 10.1007/s11095-024-03808-w. Epub 2025 Jan 23.
7
Amorphous Solid Dispersions of Glycyrrhetinic Acid: Using Soluplus, PVP, and PVPVA as the Polymer Matrix to Enhance Solubility, Bioavailability, and Stability.甘草次酸的无定形固体分散体:使用聚乙烯己内酰胺-聚乙酸乙烯酯-聚乙二醇接枝共聚物(Soluplus)、聚乙烯吡咯烷酮(PVP)和聚乙烯吡咯烷酮-醋酸乙烯酯共聚物(PVPVA)作为聚合物基质来提高溶解度、生物利用度和稳定性。
AAPS PharmSciTech. 2024 Dec 21;26(1):18. doi: 10.1208/s12249-024-03007-1.
8
The Continuous and Reversible Transformation of the Polymorphs of an MGAT2 Inhibitor (S-309309) from the Anhydrate to the Hydrate in Response to Relative Humidity.MGAT2抑制剂(S-309309)多晶型物从无水物到水合物随相对湿度的连续且可逆转变
Pharmaceutics. 2024 Jul 17;16(7):949. doi: 10.3390/pharmaceutics16070949.
9
Preparation and Evaluation of Berberine-Excipient Complexes in Enhancing the Dissolution Rate of Berberine Incorporated into Pellet Formulations.制备和评价小檗碱赋形剂复合物以提高小檗碱微丸制剂的溶出速率。
AAPS PharmSciTech. 2024 Jul 3;25(6):154. doi: 10.1208/s12249-024-02863-1.
10
Data-Driven Modeling of the Spray Drying Process. Process Monitoring and Prediction of the Particle Size in Pharmaceutical Production.喷雾干燥过程的数据驱动建模。制药生产中粒度的过程监测与预测。
ACS Omega. 2024 Jun 7;9(24):25678-25693. doi: 10.1021/acsomega.3c08032. eCollection 2024 Jun 18.
利用太赫兹光谱技术在 3D 打印无定形固体分散体中检测结晶度。
Mol Pharm. 2022 Jul 4;19(7):2380-2389. doi: 10.1021/acs.molpharmaceut.2c00163. Epub 2022 Jun 7.
4
Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation.通过聚合物盐形成改善肠溶性聚合物及其无定形固体分散体的溶出度。
Int J Pharm. 2022 Jun 25;622:121886. doi: 10.1016/j.ijpharm.2022.121886. Epub 2022 Jun 1.
5
Assessing the Interrelationship of Microstructure, Properties, Drug Release Performance, and Preparation Process for Amorphous Solid Dispersions Via Noninvasive Imaging Analytics and Material Characterization.通过非侵入性成像分析和材料表征评估无定形固体分散体的微观结构、性质、药物释放性能和制备工艺之间的相互关系。
Pharm Res. 2022 Dec;39(12):3137-3154. doi: 10.1007/s11095-022-03308-9. Epub 2022 Jun 3.
6
Preformulation Studies of Ezetimibe-Simvastatin Solid Dispersions in the Development of Fixed-Dose Combinations.依折麦布-辛伐他汀固体分散体在固定剂量复方制剂研发中的处方前研究
Pharmaceutics. 2022 Apr 22;14(5):912. doi: 10.3390/pharmaceutics14050912.
7
Aversion liquid-filled drug releasing capsule (3D-RECAL): A novel technology for the development of immediate release abuse deterrent formulations using a fused deposition modelling (FDM) 3D printer.厌恶感填充药物释放胶囊(3D-RECAL):一种使用熔融沉积建模(FDM)3D 打印机开发即时释放的防滥用配方的新技术。
Int J Pharm. 2022 Jun 10;621:121804. doi: 10.1016/j.ijpharm.2022.121804. Epub 2022 May 6.
8
Investigating the Potential of Ethyl Cellulose and a Porosity-Increasing Agent as a Carrier System for the Formulation of Amorphous Solid Dispersions.研究乙基纤维素和增孔剂作为无定形固体分散体制备载体系统的潜力。
Mol Pharm. 2022 Aug 1;19(8):2712-2724. doi: 10.1021/acs.molpharmaceut.1c00972. Epub 2022 Apr 27.
9
Comparison of Differential Scanning Calorimetry, Powder X-ray Diffraction, and Solid-state Nuclear Magnetic Resonance Spectroscopy for Measuring Crystallinity in Amorphous Solid Dispersions - Application to Drug-in-polymer Solubility.差示扫描量热法、粉末X射线衍射法和固态核磁共振光谱法用于测定无定形固体分散体结晶度的比较——在药物-聚合物溶解度中的应用
J Pharm Sci. 2022 Oct;111(10):2765-2778. doi: 10.1016/j.xphs.2022.04.004. Epub 2022 Apr 11.
10
Combining enabling formulation strategies to generate supersaturated solutions of delamanid: In situ salt formation during amorphous solid dispersion fabrication for more robust release profiles.结合使能制剂策略以生成地拉米韦的过饱和溶液:在无定形固体分散体制备过程中进行原位成盐以实现更稳定的释放曲线。
Eur J Pharm Biopharm. 2022 May;174:131-143. doi: 10.1016/j.ejpb.2022.04.002. Epub 2022 Apr 9.